Sibylla Biotech
ID: 13359757Developer of patent-based software designed to apply algorithms and drug design protocols. The company's software focuses on drug discovery protocols based on original reaction path sampling and data reduction algorithms to avoid folding and thus bring the protein to degradation.
1
Funding Rounds
$23.0m
Money raised
Recent Funding Rounds
Overview
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
Funding series
Funding Series Analysis
The company Sibylla Biotech has raised a total of $23m in funding over 1 rounds.
Key Insights:
- Sibylla Biotech September 2022 Series A Funding Round: $23m